These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 262962)

  • 1. [Absorption and urinary elimination of pyrazinamid administered alone or in combination with isoniazid and rifampicin].
    Boulahbal F; Khaled S; Bouhassen H; Larbaoui D
    Arch Inst Pasteur Alger; 1978-1979; 53():165-85. PubMed ID: 262962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical effect of isoniazid on the activity of rifampin-pyrazinamide combination in a mouse model of tuberculosis.
    Almeida D; Nuermberger E; Tasneen R; Rosenthal I; Tyagi S; Williams K; Peloquin C; Grosset J
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4178-84. PubMed ID: 19620331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrazinamide serum levels in childhood tuberculosis.
    Thee S; Detjen A; Wahn U; Magdorf K
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1099-101. PubMed ID: 18713511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide.
    Lecoeur HF; Truffot-Pernot C; Grosset JH
    Am Rev Respir Dis; 1989 Nov; 140(5):1189-93. PubMed ID: 2817579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The disposition of antituberculous drugs in plasma of elderly patients. II. Isoniazid, rifampicin and pyrazinamide.
    Walubo A; Chan K; Woo J; Chan HS; Wong CL
    Methods Find Exp Clin Pharmacol; 1991 Oct; 13(8):551-6. PubMed ID: 1956210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tolerability and efficacy of a 6-month antituberculosis regimen containing rifampicin, isoniazid and pyrazinamide.
    Kleeberg HH; Swart DJ; Carey SM
    S Afr Med J; 1983 Oct; 64(18):693-6. PubMed ID: 6623275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetration of isoniazid, rifampicin and pyrazinamide in tuberculous pleural effusion and psoas abscess.
    Jutte PC; Rutgers SR; Van Altena R; Uges DR; Van Horn JR
    Int J Tuberc Lung Dis; 2004 Nov; 8(11):1368-72. PubMed ID: 15581207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of isoniazid, rifampicin and pyrazinamide (in free combination or fixed-triple formulation) in intermittent antituberculous chemotherapy.
    Acocella G; Luisetti M; Grassi GG; Peona V; Pozzi E; Grassi C
    Monaldi Arch Chest Dis; 1993; 48(3):205-9. PubMed ID: 8369784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low level of compliance with tuberculosis treatment in children: monitoring by urine tests.
    Palanduz A; Gültekin D; Erdem E; Kayaalp N
    Ann Trop Paediatr; 2003 Mar; 23(1):47-50. PubMed ID: 12648324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bioavailability of isoniazid, rifampin, and pyrazinamide in two commercially available combined formulations designed for use in the short-course treatment of tuberculosis.
    Ellard GA; Ellard DR; Allen BW; Girling DJ; Nunn AJ; Teo SK; Tan TH; Ng HK; Chan SL
    Am Rev Respir Dis; 1986 Jun; 133(6):1076-80. PubMed ID: 3717760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC; Lee YC
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sterilizing activity of the main drugs on the mouse experimental tuberculosis (author's transl)].
    Grosset J; Truffot C; Fermanian J; Lecoeur H
    Pathol Biol (Paris); 1982 Jun; 30(6):444-8. PubMed ID: 6810288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between allopurinol and pyrazinamide.
    Lacroix C; Guyonnaud C; Chaou M; Duwoos H; Lafont O
    Eur Respir J; 1988 Oct; 1(9):807-11. PubMed ID: 3229478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The disposition of antituberculous drugs in plasma of elderly patients. I. Isoniazid and hydrazine metabolite.
    Walubo A; Chan K; Woo J; Chan HS; Wong CL
    Methods Find Exp Clin Pharmacol; 1991 Oct; 13(8):545-50. PubMed ID: 1956209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic activity of R207910 combined with pyrazinamide against murine tuberculosis.
    Ibrahim M; Andries K; Lounis N; Chauffour A; Truffot-Pernot C; Jarlier V; Veziris N
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1011-5. PubMed ID: 17178794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoniazid, rifampicin and pyrazinamide plasma concentrations 2 and 6 h post dose in patients with pulmonary tuberculosis.
    Fahimi F; Tabarsi P; Kobarfard F; Bozorg BD; Goodarzi A; Dastan F; Shahsavari N; Emami S; Habibi M; Salamzadeh J
    Int J Tuberc Lung Dis; 2013 Dec; 17(12):1602-6. PubMed ID: 24200276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
    Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R
    Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics of antitubercular agents in man].
    Acocella G
    Minerva Med; 1984 Mar; 75(11):561-3. PubMed ID: 6424054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis.
    Zimhony O; Cox JS; Welch JT; Vilchèze C; Jacobs WR
    Nat Med; 2000 Sep; 6(9):1043-7. PubMed ID: 10973326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.